Hbm Healthcare Investments

What is Hbm Healthcare Investments?

HBM Healthcare Investments is an investment firm headquartered in Zug, Switzerland that specializes in the healthcare sector. With a commitment to human medicine, biotechnology, medical technology, diagnostics, and related areas, they operate by directly investing in companies that show potential in these fields. Their investment portfolio is globally diversified with private and publicly listed companies engaged in health.

They focus on companies that are part of a rapidly growing economic sector influenced by demographic shifts such as population growth and aging, medical advancements, rising affluence especially in emerging markets, and increased access to medical products and services. The firm recognizes a continuous need for novel therapeutic options for a growing number of diseases and holds an optimistic view on the incessant innovation in products, services, and business models within the health industry.

Underpinning their investment thesis is the understanding that the health market is one of the significant and fastest-growing sectors globally. This is fueled by the vitality of demands and opportunities which they aim to tap into.

They boast of an attractive value development over the years, where the intrinsic value (NAV) per share and the share price of HBM Healthcare Investments have exhibited promising trends, along with a consistent distribution yield of 3 to 5 percent annually. Their website reveals a strong performance, showcasing a profit of CHF 66 million for the first nine months of the fiscal year 2024/2025.

Their approach to investment is backed by a strategy that is keen on understanding the global health market and targeting more opportunities for investments in the sector. By maintaining an up-to-date and substantial knowledge base on the dynamic health market, HBM Healthcare Investments is poised to empower their portfolio companies in achieving growth and innovation.